Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection

Author： Dietrich E.S.   Schubert B.   Ebner W.   Daschner F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.1, 2001-01, pp. : 79-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections

By Walters D.J.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 551-561

Adis International

Access to resources Recommend Favorite

Tazobactam/piperacillin dominates in intra-abdominal infection

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 303, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Tazobactam/piperacillin dominates in intra-abdominal infection

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK

By Jansen Jeroen P.  

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 1045-1056

Adis International

Access to resources Recommend Favorite

Imipenem/cilastatin: Drug hypersensitivity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite